-
Mashup Score: 5The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia - 5 day(s) ago
Nature Cancer – Lawson et al. show that genetic inactivation of Phd1 or Phd2 hinders progression of AML and compromises leukemic stem cells. They develop a selective PHD inhibitor IOX5 and show…
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 15Digital therapy app significantly improves speech in stroke patients - 2 month(s) ago
A UCL-developed app that provides speech therapy for people with the language disorder aphasia has been found to significantly improve their ability to talk.
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet-
Digital #therapy app significantly improves speech in stroke patients @uclnews @TheLancet https://t.co/NK2Ucolteh
-
-
Mashup Score: 1For Better Results, Focus On Your Self-Care Between Therapy Sessions - 4 month(s) ago
It’s important to find ways to support your mental health in between appointments with your therapist.
Source: www.henryford.comCategories: General Medicine News, General HCPsTweet-
Self-care needs to be as much of a priority as your #therapy appointments. https://t.co/gIAms7xxDu
-
-
Mashup Score: 0
Researchers sought to examine the association between receiving physical therapy and falls that require medical care within 12 months of dizziness presentation.
Source: www.neurologyadvisor.comCategories: Latest Headlines, NeurologyTweet-
Among patients with #dizziness, the risk for falls was the lowest 3 to 12 months after physical #therapy. ➡️ https://t.co/J11jumiQ4d #NeuroTwitter
-
-
Mashup Score: 14Growing placebo response in TMS treatment for depression: a meta-analysis of 27-year randomized sham-controlled trials - 7 month(s) ago
Nature Mental Health – The authors conducted a systematic review and meta-analysis to identify predictors of placebo response in repetitive transcranial magnetic stimulation treatment for depression.
Source: www.nature.comCategories: General Medicine News, Latest HeadlinesTweet-
#PlaceboEffect found to be growing stronger for transcranial magnetic stimulation #therapy used for depression @NatMentHealth https://t.co/2hEd3sS77p https://t.co/fcuMurlAcl
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Novel research from @BrighamWomens has developed a promising new cell #therapy to eliminate established #glioblastoma tumors and to act as a #cancer vaccine to induce long-term #immunity. Read more about the study: https://t.co/Lasd2daDSp https://t.co/z7MBwDJcaO
-
-
Mashup Score: 0Housing Mobility Intervention and the Impact on Pediatric Asthma Morbidity: A Novel Asthma-Directed Therapy - 8 month(s) ago
Pollack CE, Roberts LC, Peng RD, Cimbolic P, Judy D, Balcer-Whaley S, et al. Association of a housing mobility program with childhood asthma symptoms and exacerbations. JAMA 2023;329:1671-81.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Housing #Mobility #Intervention and the #Impact on #Pediatric #Asthma #Morbidity: A Novel Asthma-Directed #Therapy https://t.co/XUzqhJX2kK
-
-
Mashup Score: 47Novel therapy for ischaemia with no obstructive coronary arteries - 8 month(s) ago
Coronary vascular dysfunction causes microvascular angina and vasospastic angina, which are prevalent clinical endotypes of myocardial ischaemia with no obstruc
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @ehj_ed: Novel therapy for ischaemia with no obstructive coronary arteries. Read more in #EHJ: https://t.co/w7ilG6ZnJV #INOCA #therapy…
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
About 40% of patients with large B-cell #lymphoma (LBCL) will experience a relapse after treatment with standard-of-care regimens such as R-CHOP. The use of axi-cel is being evaluated as a first-line #therapy in patients with LBCL. https://t.co/aYkBgL2RUr #CancerResearch https://t.co/NZxUgE4PgE
-
-
Mashup Score: 0Abemaciclib in Focus: A Look at monarchE Trial - 10 month(s) ago
Abemaciclib, a CDK4 & 6 inhibitor, has shown a sustained benefit in invasive disease-free survival in high-risk EBC, as seen in the monarchE trial. While effective, abemaciclib does have side effects, and these can be more pronounced in older patients. Diarrhea, fatigue, and neutropenia are among the common ad…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Breastcancer is a prevalent global issue. Our article highlights #abemaciclib, a promising #therapy offering improved prognosis and life quality, includes an interview with Dr. Erika Hamilton from #ASCO23. @ErikaHamilton9 @SarahCannonDocs https://t.co/iW85GQjw8r
-
💫NEW CONTENT @NatureCancer “The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia” #therapy https://t.co/VoBNPZBSa9